Dr. Sun has more than 14 years of biotechnology management experience in the US in business and product development, strategic planning, partnering, and licensing. He founded A&G Pharmaceutical Inc, in 2000. Under his leadership, within 18 months, A&G reached an agreement to co-develop a monoclonal antibody-based drug with MedImmune for treatment of human breast cancer.
Dr. Sun received MS degrees in chemical engineering from the Chinese Academy of Light Industry and PhD in biochemistry/cell biology from Tsinghua University, Beijing, China. Dr. Sun spent two years as a postdoctoral fellow in Dr. David Barnes’ lab at Oregon State University, where he established primary cultures of zebrafish embryonic stem cells.
Dr. Sun founded Welson Phamaceuticals, Inc and AbMax Biotechnology Co., Ltd after coming back to China in 2004. Dr. Sun is a professor of Beijing Normal University.